Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757714 | SCV000886040 | benign | not provided | 2017-09-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001206753 | SCV001378077 | uncertain significance | Capillary malformation-arteriovenous malformation syndrome | 2025-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 22 of the RASA1 protein (p.Gly22Cys). This variant is present in population databases (rs371413736, gnomAD 0.01%). This missense change has been observed in individual(s) with capillary malformation–arteriovenous malformation (PMID: 24038909). ClinVar contains an entry for this variant (Variation ID: 618857). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001332196 | SCV001524438 | uncertain significance | Capillary malformation-arteriovenous malformation 1 | 2019-01-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000757714 | SCV001814306 | likely benign | not provided | 2020-10-13 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24038909) |